Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Engineering humoral immunity as prophylaxis or therapy.

Engineering humoral immunity as prophylaxis or therapy. Curr Opin Immunol. 2015 Aug; 35:113-22.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.